NSE filing, NSE: ARTNIRMAN. Summary written from the filing by ALFA Finder's alert engine.
ART Nirman Ltd: key numbers
- Share price
- ₹37.15
- Market cap
- ₹92.71 Cr
- Revenue (annual)
- ₹33.24 Cr
- Net profit (annual)
- ₹0.52 Cr
- P/E (TTM)
- 213.4×Sector 34.0×
- Promoter holding
- 73.75%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ART Nirman Ltd
All →ART Nirman Board Meeting Date
Art Nirman Limited will hold a board meeting on 05-Nov-2026 to consider unaudited standalone half-yearly results for September 2026. The trading window closes from 01-Jul-2026 until 07-Nov-2026.
ART Nirman Annual General Meeting
Art Nirman Limited held its 15th Annual General Meeting on September 26, 2026. The meeting covered routine business, director appointments, and various special business resolutions.
ART Nirman Results Correction
Art Nirman Limited submitted a revised XBRL filing for the financial results for the quarter ended June 30, 2026, in response to an exchange query.
ART Nirman Other Announcement
The Company is notifying shareholders about the dispatch of a letter providing the Annual Report for FY 2025-26 and the 15th AGM details.
ART Nirman Annual General Meeting
Art Nirman Limited filed the Notice of its 15th Annual General Meeting scheduled for September 26, 2026, alongside its Annual Report for FY 2025-26.
ART Nirman Q1 FY27 Results: Net Loss of ₹0.2 Cr, Loss Widens
ART Nirman Ltd reported revenue from operations of ₹2.1 Cr (+40.0% YoY) and a net loss of ₹0.2 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.2 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.